SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Drug reformulations and repositioning in the pharmaceutical industry and their impact on market access: regulatory implications
5 references·0 citing·12 second hop
Drug reformulations and repositioning in the pharmaceutical industry and their impact on market access: regulatory implications (2014)Drug reformulations and repositioning in …Open-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseases (2013)Open-source approaches for th…Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature (2013)Drug reformulations and repos…Repositioned drugs: integrating intellectual property and regulatory strategies (2011)Repositioned drugs: integrati…Intellectual property and other legal aspects of drug repurposing (2011)Intellectual property and oth…Repurposing Strategies for Therapeutics (2010)Repurposing Strategies for Th…Lessons from 60 years of pharmaceutical innovation (2009)How does the partner type in R&D alliances impact technological innovation performance? A study on the Korean biotechnology industry (2015)Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New Treatments (2020)National Innovation Systems: A Comparative Analysis (1993)National innovation systems: A comparative analysis (1993)Rare diseases, orphan drugs and their regulation: questions and misconceptions (2010)Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research (2021)Advancing drug repurposing research: Trends, collaborative networks, innovation and knowledge leaders (2022)The value of drug repositioning in the current pharmaceutical market (2009)The value of drug repositioning in the current pharmaceutical market (2009)Drug repurposing and the prior art patents of competitors (2014)Tecfidera®: an Approach for Repurposing (2014)
this work references cited by second hop

References

  • 2010Repurposing Strategies for Therapeutics165 cited
  • 2013Open-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseases103 cited
  • 2013Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature65 cited
  • 2011Repositioned drugs: integrating intellectual property and regulatory strategies64 cited
  • 2011Intellectual property and other legal aspects of drug repurposing27 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work